23andMe Gets NHGRI Grant | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetic testing firm 23andMe said today it has received a $190,000 grant from the National Institutes of Health to validate its platform for pharmacogenomics research.

The Mountain View, Calif.-based company received the funding as part of the American Recovery and Reinvestment Act of 2009 from NIH's National Human Genome Research Institute.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.